Evidence Grading
"Evidence is strongest at the in-vitro level (Tyrosinase/MITF inhibition) and weakest for controlled human melasma trials on this exact blend."
Formulation Overview
Key Lead Assets
Curcuminoid-Rich Turmeric Extract
Targets Tyrosinase/MITF inhibition; strong antioxidant profile.
α-Santalol-Rich Sandalwood Fraction
Potent direct Tyrosinase inhibitor with documented anti-tan effects.
Ranked Biological Targets
Functional Pathways
Core Mechanism Hypothesis
Mild inhibition of melanogenesis via multi-node pathway modulation combined with gentle physical exfoliation and potent ROS scavenging.
High Caution / Avoid
- Active facial eczema or rosacea flares
- Broken skin or open acne lesions
- Known hypersensitivity to Camphor
- Recent chemical peels or laser work
Common Side Effects
- Temporary yellow skin staining (Turmeric)
- Transient stinging/cooling (Camphor)
- Mild redness from exfoliation
Interaction Precautions
- Avoid concurrent AHA/BHA/Retinoids
- Don't layer with Triple-Cream therapies
- Daily Sunscreen (SPF 30+) mandatory
India Regulatory Claims Matrix
| Claim Type | Example Wording | Risk Level |
|---|---|---|
| Cosmetic | "Imparts natural glow and brightness" | LOW |
| Texture | "Gently exfoliates for smooth skin" | LOW |
| Tone | "May help even out perceived skin tone" | MEDIUM |
| Medical | "Treats melasma and dark spots" | HIGH |
8-Week DCT Study Design
Clinician Consultation Summary
"Position as a rinse-off cosmetic adjunct. Benefits are modest brightening, not disease-modification. Maintain SOC melasma therapy and strict SPF."